| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 57223-12-8 | 1-Methoxy-5-Methyl-1H-Benzotriazole | C8H9N3O |
| 57223-18-4 | 1-Nonen-3-Yne | C9H14 |
| 57224-13-2 | Methyl 2-Cyano-L-Prolinate | C7H10N2O2 |
| 57224-14-3 | Methyl 3,4-Dihydro-2H-Pyrrole-5-Carboxylate | C6H9NO2 |
| 57224-15-4 | 2-Cyano-N-Methylprolinamide | C7H11N3O |
| 57224-26-7 | 2,3,6,7-Tetrahydro-2-Methyl-3-Methylene-Pyrrolo[1,2-a]Pyrazine-1,4-Dione | |
| 57224-38-1 | 2,3-Dimethylhexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione | C9H14N2O2 |
| 57224-50-7 | 4-Methyl-L-leucine | C7H15NO2 |
| 57224-63-2 | N-Carbobenzyloxy-L-threonine methyl ester | C13H17NO5 |
| 57224-68-7 | 4-(Pentyloxy)benzeneethanamine | C13H21NO |
| 57225-25-9 | N2-[(1,1-Dimethylethoxy)carbonyl]-N5-[(phenylmethoxy)carbonyl]-L-ornithine 2,5-dioxo-1-pyrrolidinyl ester | C22H29N3O8 |
| 57226-04-7 | 2-(4-Chlorophenoxy)-2-(4-Chlorophenyl)Acetic Acid | C14H10Cl2O3 |
| 57226-07-0 | Fluoxetine | C17H18F3NO |
| 57226-61-6 | Nisoxetine | C17H21NO2 |
| 57226-68-3 | gamma-[4-(Trifluoromethyl)Phenoxy]-Benzenepropanamine Hydrochloride (1:1) | C16H17ClF3NO |
| 57226-72-9 | (2-Amino-4,5,6,7-Tetrahydrothieno[2,3-c]Pyridin-3-Yl)(Phenyl)Methanone | C14H14N2OS |
| 57226-96-7 | 1-Phenyl-1H-[1,2,4]triazole-3-carboxylic acid methyl ester | C10H9N3O2 |
| 57227-08-4 | alpha-(Benzoylamino)-4-(benzoyloxy)-N,N-dipropylbenzenepropanamide | C29H32N2O4 |
| 57227-09-5 | N-Benzoyl-DL-tyrosyl-N',N'-dipropylamide | C22H28N2O3 |
| 57227-17-5 | Sevopramide | C29H43N3O3 |
| 57227-20-0 | (+-)-alpha-(Benzoylamino)-4-(4-(diethylamino)butoxy)-N,N-dipropylhydrocinnamamide oxalate | C32H47N3O7 |
| 57227-28-8 | 4-(3-Chloropropyl)-1-piperazineethanol | C9H19ClN2O |
| 57228-29-2 | (2S)-2-Benzyloxycarbonylamino-3-(4-Benzyloxycarbonyloxyphenyl)Propanoic Acid | C25H23NO7 |
| 57228-55-4 | [(S)-1-[[4-[2-(Dimethylamino)Ethoxy]Phenyl]Methyl]-2-(Dipropylamino)-2-Oxoethyl]Carbamic Acid p-Nitrobenzyl Ester | C27H38N4O6 |
| 57228-66-7 | 3-Cholesteryl-N-Octylcarbamate | C36H63NO2 |
| 57229-25-1 | 4-Phospho D-Erythronate | C4H9O8P |
| 57229-37-5 | Pyrazinuric Acid | C7H7N3O3 |
| 57229-41-1 | N-(9-Hydroxy-9H-Fluoren-2-Yl)Acetamide | C15H13NO2 |
| 57229-67-1 | N-tert-Butoxycarbonyl-L-tryptophan benzyl ester | C23H26N2O4 |
| 57229-73-9 | N-(1-Oxododecyl)-DL-aspartic acid | C16H29NO5 |
| 57229-74-0 | (2S)-4-Amino-2-hydroxy-4-oxobutanoic acid | C4H7NO4 |
| 57229-92-2 | 3’N-Benzyl Biotin | C17H22N2O3S |
| 57230-01-0 | N-(Chloroacetyl)-L-Methionine | C7H12ClNO3S |
| 57230-09-8 | 2-Amino-1-(1,3,5,7-Cyclooctatetraen-1-Yl)Ethanol | C10H13NO |
| 57230-13-4 | 2-Cyclooctyl-2-Hydroxyethylamine | C10H21NO |
| 57230-48-5 | Dianhydro-3,4-Diacetylgalactitol | C10H14O6 |
| 57230-49-6 | 1,2:5,6-Dianhydro-Galactitol Bis(Benzenepropionate) | C24H26O6 |
| 57230-51-0 | 2-(Trifluoroacetyl)Phenyl Acetate | C10H7F3O3 |
| 57231-31-9 | 1-[(3,4-Dihydroxyphenyl)Methyl]-1,2,3,4-Tetrahydro-2-Methyl-(1S)-6,7-Isoquinolinediol | C17H19NO4 |
| 57231-32-0 | (R)-1-[(3,4-Dihydroxyphenyl)Methyl]-1,2,3,4-Tetrahydro-2-Methylisoquinoline-6,7-Diol | C17H19NO4 |
| 57232-94-7 | [1-Ethylbenz[cd]Indol-2(1H)-Ylidene]Malononitrile | C16H11N3 |
| 57232-98-1 | N-[[4-[(1-Amino-9,10-Dihydro-4-Hydroxy-9,10-Dioxo-2-Anthryl)Oxy]Phenyl]Methyl]-2-Chloroacetamide | C23H17ClN2O5 |
| 57233-04-2 | N,2-Bis(Isopropyl)-5-Methylcyclohexanecarboxamide | C14H27NO |
| 57233-12-2 | N,N-Diethyl-2-Isopropyl-5-Methylcyclohexanecarboxamide | C15H29NO |
| 57233-37-1 | N,N-Di-Sec-Butylacetamide | C10H21NO |
| 57233-79-1 | Hexadecyl [4-Chloro-3-[[4,5-Dihydro-5-Oxo-1-(2,4,6-Trichlorophenyl)-1H-Pyrazol-3-Yl]Amino]Phenyl]Carbamate | C32H42Cl4N4O3 |
| 57233-86-0 | (S)-1-(4-Nitrophenyl)ethylamine hydrochloride | C8H10N2O2 HCl |
| 57233-98-4 | 3-Bromothiophen-2,4-Dicarboxylic Acid | C6H3BrO4S |
| 57234-00-1 | 2,2'-Diformyl-3,3'-Bithiophene-4,4'-Dicarboxylic Acid | C12H6O6S2 |
| 57234-11-4 | 2-Hydroxy-2-(4-Morpholinyl)Cyclopentanone | C9H15NO3 |